For the Inventor, By the Inventor

Enter inventor name

Hopkinton, MA, United States of America

Stephen E Zale

USPTO Granted Patents = 50 (Patent Applications = 25)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 4.0

ph-index = 27

Forward Citations = 2,433(Granted Patents)

Forward Citations (Not Self Cited) = 2,207(Dec 10, 2025)

Location History:

Hopkington, MA (US) (1997 - 1999)
Hopkinton, MA (US) (2002 - 2024)

Company Filing History:

Bind Therapeutics, Inc.

Bind Biosciences, Inc.

Pfizer Corporation

Alkermes Controlled Therapeutics, Inc.

Lyndra Therapeutics, Inc.

6. 2 out of 8,373

Massachusetts Institute of Technology

7. 2 out of 1,373

The Brigham and Women's Hospital, Inc.

Alkermes Controlled Therapeutics, Inc. I

Alkermas Controlled Therapeutics, Inc.

11. 1 out of 160

Alkermes Pharma Ireland Limited

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Gastric Residence Systems

Therapeutic Nanoparticles

Cancer Cell Targeting

Polymeric Nanoparticles

Sustained Drug Delivery

Lyophilization Techniques

Targeted Drug Delivery

Injectable Suspensions

Biologically Active Agents

Microencapsulation

Vinca Alkaloids

mTOR Inhibitors

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109305 - Materials architecture for gastric residence systems (2024-10-08),

2. 12023406 - Gastric residence systems with release rate-modulating films (2024-07-02),

3. 11576866 - Gastric residence systems for sustained delivery of adamantane-class drugs (2023-02-14),

4. 10137088 - Therapeutic nanoparticles having EGFR ligands and methods of making and using same (2018-11-27),

5. 10071056 - Cancer cell targeting using nanoparticles (2018-09-11),

6. 9872848 - Stable formulations for lyophilizing therapeutic particles (2018-01-23),

7. 9835572 - Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers (2017-12-05),

8. 9579386 - Drug loaded polymeric nanoparticles and methods of making and using same (2017-02-28),

9. 9579284 - Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same (2017-02-28),

10. 9498443 - Stable formulations for lyophilizing therapeutic particles (2016-11-22),

11. 9393310 - Drug loaded polymeric nanoparticles and methods of making and using same (2016-07-19),

12. 9351933 - Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same (2016-05-31),

13. 9308179 - Long circulating nanoparticles for sustained release of therapeutic agents (2016-04-12),

14. 9295727 - Cancer cell targeting using nanoparticles (2016-03-29),

15. 9198874 - Long circulating nanoparticles for sustained release of therapeutic agents (2015-12-01),

Title: The Innovative Journey of Stephen E Zale

Introduction: Stephen E Zale, a talented inventor hailing from Hopkinton, MA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Stephen E Zale's latest patents include cutting-edge advancements in the fields of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Stephen E Zale has worked for renowned tech companies, leading research institutions, and universities, where he has spearheaded numerous projects that have revolutionized their respective industries.

Collaborations: Throughout his career, Stephen E Zale has collaborated with top-notch engineers, scientists, and researchers, fostering a culture of innovation and excellence that has resulted in the successful development of groundbreaking technologies.

Conclusion: Stephen E Zale's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a visionary inventor whose work continues to shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…